company goodrx 
STAT
FEBRUARY 1, 2023
The Federal Trade Commission on Wednesday accused GoodRx, the prescription drug discount platform, of sharing sensitive personal information about its users’ prescriptions and health conditions with big tech companies. GoodRx, which also runs a marketplace for telehealth services, agreed to pay a $1.5
STAT
APRIL 4, 2023
For the first time, Mark Cuban’s Cost Plus Drug Company is selling medicines made by a large drug manufacturer directly to consumers at a greatly reduced price, the latest sign that the billionaire is trying to make good on his vow to disrupt the opaque pharmaceutical supply chain. The average retail price is $676.14.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MAY 2, 2023
million Black Americans — roughly 1 in 3 — live in counties with little or no access to heart specialists, according to a report from GoodRx, a telehealth company that provides drug discounts and also researches health trends. Read the rest…
STAT
FEBRUARY 1, 2023
On Wednesday, the Federal Trade Commission made history by enforcing, for the first time, its power to go after companies that don’t notify consumers about health data breaches. The agency said it will fine GoodRx $1.5
STAT
AUGUST 9, 2023
This year has seen the Federal Trade Commission crack down on digital health companies’ irresponsible data use. Since February, it has charged four companies with improperly handling sensitive health information — starting with the first-ever enforcement of its long-stagnant Health Breach Notification Rule, against GoodRx.
STAT
DECEMBER 8, 2022
In his latest bid to expand access to lower-cost medicines, Mark Cuban’s Cost Plus Drug Company will offer discounts directly to a company run by a coalition of 40 large private and public employers, cutting out the usual middlemen in the nation’s opaque pharmaceutical supply chain.
PharmaVoice
OCTOBER 17, 2022
To address this gap, GoodRx is partnering with pharmaceutical companies to improve cost transparency and communication between patients and providers. New findings reveal an out-of-pocket cost gap between brand-name and generic prescriptions.
Expert insights. Personalized for you.
106 
Let's personalize your content